Autoimmunity in Patients with Wiskott-Aldrich Syndrome (WAS) after Hematopoietic Stem Cell Transplantation (HSCT)- a Single Center Experience | Synapse
March 3, 2026
Autoimmunity in Patients with Wiskott-Aldrich Syndrome (WAS) after Hematopoietic Stem Cell Transplantation (HSCT)- a Single Center Experience
Key Points
Autoimmunity often develops following hematopoietic stem cell transplantation, impacting patients with Wiskott-Aldrich Syndrome.
Thrombocytopenia—an abnormally low platelet count—remains a critical concern in this population after receiving transplants.
Investigation of immune response alterations post-transplant provides insight into management strategies for these patients.
The findings highlight the need for further understanding of post-transplant complications and immune changes.